Rosenthal R C
Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison.
Vet Clin North Am Small Anim Pract. 1990 Jul;20(4):1093-104. doi: 10.1016/s0195-5616(90)50086-8.
Canine LSA is a fatal disease if untreated, but fortunately it is also a disease that is very responsive to therapeutic intervention. It is likely that most cases seen and treated by practitioners will be managed with the currently effective drugs and with new protocols as they are developed. Other approaches, including immunotherapy and BMT, are likely to remain more in the arena of the academic institution but should be available in the referral setting for appropriate cases. Great strides have been made in the less than 30 years that canine LSA has been widely treated; it is reasonable that similar progress is to be expected in the years to come.
犬类淋巴细胞性浆细胞性肠炎(Canine LSA)若不治疗会是一种致命疾病,但幸运的是,它也是一种对治疗干预反应非常良好的疾病。从业者所诊治的大多数病例可能会采用目前有效的药物以及随着新方案的研发而使用新方案来进行管理。其他方法,包括免疫疗法和骨髓移植(BMT),可能更多地仍处于学术机构的研究范畴,但在转诊情况下对于合适的病例应该是可行的。在犬类LSA得到广泛治疗的不到30年时间里已经取得了巨大进展;在未来几年有望取得类似的进展是合理的。